Mehdi Hamadani, Professor of Internal Medicine at the Medical College of Wisconsin, shared on X:
“Current status of ADCs in lymphoma DLBCL.
Loved developing this invited piece with two lymphoma rising stars Gulrayz Ahmed and Taha A.”
The potential of antibody-drug conjugates for effective therapy in diffuse large B-cell lymphoma
Authors: Gulrayz Ahmed, Mehdi Hamadani and Taha Al-Juhaishi.
Mehdi Hamadani is a Professor of Internal Medicine at the Medical College of Wisconsin, where he also serves as Director of the Blood and Marrow Transplant (BMT) and Cellular Therapy Program. Additionally, he is the Associate Scientific Director at the Center for International Blood and Marrow Transplantation Research.